Chemicals

Showing 16051–16200 of 41137 results

  • The cytochalasins are cell-permeable fungal metabolites which inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin A is an oxidized analog of cytochalasin B which uniquely inhibits HIV-1 protease (IC50 = 3 μM).{21211} Cytochalasins A and B differ from other cytochalasins in being able to rapidly and reversibly inhibit glucose transport by competitively binding glucose transporters (Ki = 4.0 and 0.6 μM, respectively).{21309,21308} Cytochalasin A also induces the phosphorylation of the tyrosine phosphatase PTP3 of Dictyostelium, activating STATc.{21304}  

     

    Brand:
    Cayman
    SKU:11327 - 1 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites which inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin A is an oxidized analog of cytochalasin B which uniquely inhibits HIV-1 protease (IC50 = 3 μM).{21211} Cytochalasins A and B differ from other cytochalasins in being able to rapidly and reversibly inhibit glucose transport by competitively binding glucose transporters (Ki = 4.0 and 0.6 μM, respectively).{21309,21308} Cytochalasin A also induces the phosphorylation of the tyrosine phosphatase PTP3 of Dictyostelium, activating STATc.{21304}  

     

    Brand:
    Cayman
    SKU:11327 - 10 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites which inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin A is an oxidized analog of cytochalasin B which uniquely inhibits HIV-1 protease (IC50 = 3 μM).{21211} Cytochalasins A and B differ from other cytochalasins in being able to rapidly and reversibly inhibit glucose transport by competitively binding glucose transporters (Ki = 4.0 and 0.6 μM, respectively).{21309,21308} Cytochalasin A also induces the phosphorylation of the tyrosine phosphatase PTP3 of Dictyostelium, activating STATc.{21304}  

     

    Brand:
    Cayman
    SKU:11327 - 5 mg

    Available on backorder

  • Cytochalasin B is a cell-permeable mycotoxin which binds to the barbed end of actin, reversibly inhibiting the elongation and shortening of actin filaments.{20528} By disrupting actin polymerization, cytochalasin B blocks diverse cellular functions, including cell division, migration, phagocytosis, exocytosis, chemotaxis, and glucose transport.{20527,20526,20524} Cytochalasin B is broadly used in cytological studies involving any of these many processes that depend on actin polymerization.{20525,20530,20529}  

     

    Brand:
    Cayman
    SKU:11328 - 1 mg

    Available on backorder

  • Cytochalasin B is a cell-permeable mycotoxin which binds to the barbed end of actin, reversibly inhibiting the elongation and shortening of actin filaments.{20528} By disrupting actin polymerization, cytochalasin B blocks diverse cellular functions, including cell division, migration, phagocytosis, exocytosis, chemotaxis, and glucose transport.{20527,20526,20524} Cytochalasin B is broadly used in cytological studies involving any of these many processes that depend on actin polymerization.{20525,20530,20529}  

     

    Brand:
    Cayman
    SKU:11328 - 10 mg

    Available on backorder

  • Cytochalasin B is a cell-permeable mycotoxin which binds to the barbed end of actin, reversibly inhibiting the elongation and shortening of actin filaments.{20528} By disrupting actin polymerization, cytochalasin B blocks diverse cellular functions, including cell division, migration, phagocytosis, exocytosis, chemotaxis, and glucose transport.{20527,20526,20524} Cytochalasin B is broadly used in cytological studies involving any of these many processes that depend on actin polymerization.{20525,20530,20529}  

     

    Brand:
    Cayman
    SKU:11328 - 5 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin C has been shown to be 10 times less toxic in mice than the related cytochalasin D (Item No. 11330), but with essentially the same biological effectiveness against cells in culture.{25080}  

     

    Brand:
    Cayman
    SKU:11329 - 1 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin C has been shown to be 10 times less toxic in mice than the related cytochalasin D (Item No. 11330), but with essentially the same biological effectiveness against cells in culture.{25080}  

     

    Brand:
    Cayman
    SKU:11329 - 5 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin D is a cell-permeable inhibitor that binds actin filaments, but not actin monomers, to inhibit polymerization at concentrations as low as 0.2 µM.{21310} In this way, it prevents the migration of tumor cells.{15841}  

     

    Brand:
    Cayman
    SKU:11330 - 1 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin D is a cell-permeable inhibitor that binds actin filaments, but not actin monomers, to inhibit polymerization at concentrations as low as 0.2 µM.{21310} In this way, it prevents the migration of tumor cells.{15841}  

     

    Brand:
    Cayman
    SKU:11330 - 10 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin D is a cell-permeable inhibitor that binds actin filaments, but not actin monomers, to inhibit polymerization at concentrations as low as 0.2 µM.{21310} In this way, it prevents the migration of tumor cells.{15841}  

     

    Brand:
    Cayman
    SKU:11330 - 5 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites which inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin E is an epoxide-containing analog of cytochalasin B (Item No. 11328) which potently and selectively inhibits the growth of endothelial cells (IC50 1 protease activity.{21309,21308,21211}  

     

    Brand:
    Cayman
    SKU:11331 - 1 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites which inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin E is an epoxide-containing analog of cytochalasin B (Item No. 11328) which potently and selectively inhibits the growth of endothelial cells (IC50 1 protease activity.{21309,21308,21211}  

     

    Brand:
    Cayman
    SKU:11331 - 10 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites which inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin E is an epoxide-containing analog of cytochalasin B (Item No. 11328) which potently and selectively inhibits the growth of endothelial cells (IC50 1 protease activity.{21309,21308,21211}  

     

    Brand:
    Cayman
    SKU:11331 - 5 mg

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin H is a potent inhibitor of actin incorporation into filaments.{25080,29763} Like cytochalasin D (Item No. 11330), it also increases the steady-state diffusion coefficients of filaments, suggesting that it stimulates filament shortening.{25080} Cytochalasin H suppresses the production of reactive oxygen species by stimulated human neutrophils, blocks endocytosis of CD59 in lymphocytes, and shows anti-angiogenic activity both in vitro and in vivo.{29673,29761,29762}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin H is a potent inhibitor of actin incorporation into filaments.{25080,29763} Like cytochalasin D (Item No. 11330), it also increases the steady-state diffusion coefficients of filaments, suggesting that it stimulates filament shortening.{25080} Cytochalasin H suppresses the production of reactive oxygen species by stimulated human neutrophils, blocks endocytosis of CD59 in lymphocytes, and shows anti-angiogenic activity both in vitro and in vivo.{29673,29761,29762}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin J is a deacetylated analog of cytochalasin H that weakly inhibits actin assembly but significantly alters mitotic spindle microtubule organization and kinetochore structure.{25080,29674} Like cytochalasin H, cytochalasin J suppresses the production of reactive oxygen species by stimulated human neutrophils.{29673}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • The cytochalasins are cell-permeable fungal metabolites that inhibit actin polymerization.{21305,21310,21312,21316} This interferes with such diverse processes as cell movement, growth, phagocytosis, degranulation, and secretion.{21307,21313,21306,21315} Cytochalasin J is a deacetylated analog of cytochalasin H that weakly inhibits actin assembly but significantly alters mitotic spindle microtubule organization and kinetochore structure.{25080,29674} Like cytochalasin H, cytochalasin J suppresses the production of reactive oxygen species by stimulated human neutrophils.{29673}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Cytosporone B is a naturally occurring agonist for the nuclear receptor Nur77 (IC50 = 0.278 nM).{28698} Activation of Nur77 with cytosporone B induces the expression of Nur77-dependent genes, including the gene for Nur77 itself.{28698} Signaling through Nur77 induces apoptosis in cancer cells and retards xenograft tumor growth.{28698} It also induces genes related to gluconeogenesis and decreases atherosclerosis progression in mice fed a high fat and high cholesterol diet.{28698,28695} Cytosporone B is brain penetrant and aggravates early brain injury in rats when given (13 mg/kg intraperitoneally) after experimentally-induced subarachnoid hemorrhage.{28694} Cytosporone B also has antibacterial properties.{28693,28696}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Cytosporone B is a naturally occurring agonist for the nuclear receptor Nur77 (IC50 = 0.278 nM).{28698} Activation of Nur77 with cytosporone B induces the expression of Nur77-dependent genes, including the gene for Nur77 itself.{28698} Signaling through Nur77 induces apoptosis in cancer cells and retards xenograft tumor growth.{28698} It also induces genes related to gluconeogenesis and decreases atherosclerosis progression in mice fed a high fat and high cholesterol diet.{28698,28695} Cytosporone B is brain penetrant and aggravates early brain injury in rats when given (13 mg/kg intraperitoneally) after experimentally-induced subarachnoid hemorrhage.{28694} Cytosporone B also has antibacterial properties.{28693,28696}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Cytosporone B is a naturally occurring agonist for the nuclear receptor Nur77 (IC50 = 0.278 nM).{28698} Activation of Nur77 with cytosporone B induces the expression of Nur77-dependent genes, including the gene for Nur77 itself.{28698} Signaling through Nur77 induces apoptosis in cancer cells and retards xenograft tumor growth.{28698} It also induces genes related to gluconeogenesis and decreases atherosclerosis progression in mice fed a high fat and high cholesterol diet.{28698,28695} Cytosporone B is brain penetrant and aggravates early brain injury in rats when given (13 mg/kg intraperitoneally) after experimentally-induced subarachnoid hemorrhage.{28694} Cytosporone B also has antibacterial properties.{28693,28696}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Cytosporone B is a naturally occurring agonist for the nuclear receptor Nur77 (IC50 = 0.278 nM).{28698} Activation of Nur77 with cytosporone B induces the expression of Nur77-dependent genes, including the gene for Nur77 itself.{28698} Signaling through Nur77 induces apoptosis in cancer cells and retards xenograft tumor growth.{28698} It also induces genes related to gluconeogenesis and decreases atherosclerosis progression in mice fed a high fat and high cholesterol diet.{28698,28695} Cytosporone B is brain penetrant and aggravates early brain injury in rats when given (13 mg/kg intraperitoneally) after experimentally-induced subarachnoid hemorrhage.{28694} Cytosporone B also has antibacterial properties.{28693,28696}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Cytostatin is a natural antitumor inhibitor of cell adhesion to extracellular matrix, blocking adhesion of B16 melanoma cells to laminin and collagen type IV in vitro (IC50s = 1.3 and 1.4 µg/ml, respectively) and B16 cells metastatic activity in mice.{31268,31270} It induces apoptosis of FS3 mouse fibrosarcoma cells (IC50 = 3.1 µg/ml).{31272} Cytostatin potently and selectively inhibits protein phosphatase 2A (PP2A; IC50 = 29 nM against the catalytic subunit), while having no effect against PP1, PP2B, or PP5.{31269,31271}  

     

    Brand:
    Cayman
    SKU:19602 -

    Available on backorder

  • CytoTrace™ Orange CMTMR is a rhodamine-based, cell-permeant, vital fluorescent dye that is retained by cells for prolonged periods (>72 hours) and is passed to daughter cells. Cells loaded with long-lasting dyes, including CMTMR, are used to follow cell trafficking and cell-to-cell interactions in vivo.{33970,33971,33972} They have also been used to estimate the growth of implanted tumor spheroids.{33969} CytoTrace™ Orange CMTMR displays excitation/emission maxima of 541/565 nm, respectively.  

     

    Brand:
    Cayman
    SKU:20696 -

    Available on backorder

  • CZ415 is an inhibitor of mammalian target of rapamycin (mTOR; Kd = 6.3 nM).{47760} It is 1,000-fold selective for mTOR over a panel of 285 kinases. CZ415 inhibits phosphorylation of S6 ribosomal protein (S6RP) and Akt in HEK293T cells (IC50s = 14.5 and 14.8 nM, respectively). It inhibits IFN-γ secretion in IL-2, anti-CD3, and anti-CD28 antibody-stimulated human whole blood (IC50 = 226 nM). CZ415 (10 mg/kg) reduces fore paw joint erythema and swelling in a mouse model of collagen-induced arthritis. It also inhibits intratumor mTOR activity and reduces tumor growth in an OCC-1 oral cavity carcinoma mouse xenograft model when administered at a dose of 20 mg/kg.{47761}  

     

    Brand:
    Cayman
    SKU:27668 - 1 mg

    Available on backorder

  • CZ415 is an inhibitor of mammalian target of rapamycin (mTOR; Kd = 6.3 nM).{47760} It is 1,000-fold selective for mTOR over a panel of 285 kinases. CZ415 inhibits phosphorylation of S6 ribosomal protein (S6RP) and Akt in HEK293T cells (IC50s = 14.5 and 14.8 nM, respectively). It inhibits IFN-γ secretion in IL-2, anti-CD3, and anti-CD28 antibody-stimulated human whole blood (IC50 = 226 nM). CZ415 (10 mg/kg) reduces fore paw joint erythema and swelling in a mouse model of collagen-induced arthritis. It also inhibits intratumor mTOR activity and reduces tumor growth in an OCC-1 oral cavity carcinoma mouse xenograft model when administered at a dose of 20 mg/kg.{47761}  

     

    Brand:
    Cayman
    SKU:27668 - 10 mg

    Available on backorder

  • CZ415 is an inhibitor of mammalian target of rapamycin (mTOR; Kd = 6.3 nM).{47760} It is 1,000-fold selective for mTOR over a panel of 285 kinases. CZ415 inhibits phosphorylation of S6 ribosomal protein (S6RP) and Akt in HEK293T cells (IC50s = 14.5 and 14.8 nM, respectively). It inhibits IFN-γ secretion in IL-2, anti-CD3, and anti-CD28 antibody-stimulated human whole blood (IC50 = 226 nM). CZ415 (10 mg/kg) reduces fore paw joint erythema and swelling in a mouse model of collagen-induced arthritis. It also inhibits intratumor mTOR activity and reduces tumor growth in an OCC-1 oral cavity carcinoma mouse xenograft model when administered at a dose of 20 mg/kg.{47761}  

     

    Brand:
    Cayman
    SKU:27668 - 25 mg

    Available on backorder

  • CZ415 is an inhibitor of mammalian target of rapamycin (mTOR; Kd = 6.3 nM).{47760} It is 1,000-fold selective for mTOR over a panel of 285 kinases. CZ415 inhibits phosphorylation of S6 ribosomal protein (S6RP) and Akt in HEK293T cells (IC50s = 14.5 and 14.8 nM, respectively). It inhibits IFN-γ secretion in IL-2, anti-CD3, and anti-CD28 antibody-stimulated human whole blood (IC50 = 226 nM). CZ415 (10 mg/kg) reduces fore paw joint erythema and swelling in a mouse model of collagen-induced arthritis. It also inhibits intratumor mTOR activity and reduces tumor growth in an OCC-1 oral cavity carcinoma mouse xenograft model when administered at a dose of 20 mg/kg.{47761}  

     

    Brand:
    Cayman
    SKU:27668 - 5 mg

    Available on backorder

  • CZC-24832 is an inhibitor of PI3K with selectivity for the γ isoform (IC50 = 1.0 μM in a PI3Kγ-dependent fMLP-induced neutrophil migration assay) with limited off target effects in kinome profiling of 154 kinases and 922 other proteins.{32561} This compound demonstrates efficacy in in vitro and in vivo models of inflammation.{32561}  

     

    Brand:
    Cayman
    SKU:-
  • CZC-24832 is an inhibitor of PI3K with selectivity for the γ isoform (IC50 = 1.0 μM in a PI3Kγ-dependent fMLP-induced neutrophil migration assay) with limited off target effects in kinome profiling of 154 kinases and 922 other proteins.{32561} This compound demonstrates efficacy in in vitro and in vivo models of inflammation.{32561}  

     

    Brand:
    Cayman
    SKU:-
  • CZC-24832 is an inhibitor of PI3K with selectivity for the γ isoform (IC50 = 1.0 μM in a PI3Kγ-dependent fMLP-induced neutrophil migration assay) with limited off target effects in kinome profiling of 154 kinases and 922 other proteins.{32561} This compound demonstrates efficacy in in vitro and in vivo models of inflammation.{32561}  

     

    Brand:
    Cayman
    SKU:-
  • CZC-24832 is an inhibitor of PI3K with selectivity for the γ isoform (IC50 = 1.0 μM in a PI3Kγ-dependent fMLP-induced neutrophil migration assay) with limited off target effects in kinome profiling of 154 kinases and 922 other proteins.{32561} This compound demonstrates efficacy in in vitro and in vivo models of inflammation.{32561}  

     

    Brand:
    Cayman
    SKU:-
  • CZC-25146 is a potent inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 4.76 nM for the human recombinant kinase).{32556} It also inhibits LRRK2G2019S, a mutant linked to neurotoxicity and Parkinson’s disease, with an IC50 value of 6.87 nM. CZC-25146 is selective for LRRK2 over a panel of kinases in HeLa cell lysates, Jurkat/Ramos mixed cell lysates, as well as whole mouse brain extracts (IC50s = >2 μM). It reduces LRRK2G2019S-induced cell injury in rat primary cortical neurons.  

     

    Brand:
    Cayman
    SKU:22931 - 1 mg

    Available on backorder

  • CZC-25146 is a potent inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 4.76 nM for the human recombinant kinase).{32556} It also inhibits LRRK2G2019S, a mutant linked to neurotoxicity and Parkinson’s disease, with an IC50 value of 6.87 nM. CZC-25146 is selective for LRRK2 over a panel of kinases in HeLa cell lysates, Jurkat/Ramos mixed cell lysates, as well as whole mouse brain extracts (IC50s = >2 μM). It reduces LRRK2G2019S-induced cell injury in rat primary cortical neurons.  

     

    Brand:
    Cayman
    SKU:22931 - 10 mg

    Available on backorder

  • CZC-25146 is a potent inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 4.76 nM for the human recombinant kinase).{32556} It also inhibits LRRK2G2019S, a mutant linked to neurotoxicity and Parkinson’s disease, with an IC50 value of 6.87 nM. CZC-25146 is selective for LRRK2 over a panel of kinases in HeLa cell lysates, Jurkat/Ramos mixed cell lysates, as well as whole mouse brain extracts (IC50s = >2 μM). It reduces LRRK2G2019S-induced cell injury in rat primary cortical neurons.  

     

    Brand:
    Cayman
    SKU:22931 - 25 mg

    Available on backorder

  • CZC-25146 is a potent inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 4.76 nM for the human recombinant kinase).{32556} It also inhibits LRRK2G2019S, a mutant linked to neurotoxicity and Parkinson’s disease, with an IC50 value of 6.87 nM. CZC-25146 is selective for LRRK2 over a panel of kinases in HeLa cell lysates, Jurkat/Ramos mixed cell lysates, as well as whole mouse brain extracts (IC50s = >2 μM). It reduces LRRK2G2019S-induced cell injury in rat primary cortical neurons.  

     

    Brand:
    Cayman
    SKU:22931 - 5 mg

    Available on backorder

  • CZC-54252 is an inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50s = 1.28 and 1.85 nM for wild-type and G2019S mutant forms of LRRK2, respectively).{32555} It has been shown to protect against neuronal injury induced by Parkinson’s disease-related LRRK2-G2019S mutant activity in primary human neurons with an EC50 value of 1 nM.{32556}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CZC-54252 is an inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50s = 1.28 and 1.85 nM for wild-type and G2019S mutant forms of LRRK2, respectively).{32555} It has been shown to protect against neuronal injury induced by Parkinson’s disease-related LRRK2-G2019S mutant activity in primary human neurons with an EC50 value of 1 nM.{32556}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CZC-54252 is an inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50s = 1.28 and 1.85 nM for wild-type and G2019S mutant forms of LRRK2, respectively).{32555} It has been shown to protect against neuronal injury induced by Parkinson’s disease-related LRRK2-G2019S mutant activity in primary human neurons with an EC50 value of 1 nM.{32556}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CZC-54252 is an inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50s = 1.28 and 1.85 nM for wild-type and G2019S mutant forms of LRRK2, respectively).{32555} It has been shown to protect against neuronal injury induced by Parkinson’s disease-related LRRK2-G2019S mutant activity in primary human neurons with an EC50 value of 1 nM.{32556}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • CZC-8004 is an aminopyrimidine that binds a range of tyrosine kinases, including ABL, BTK, FAK, FER, JAK1, SRC, SYK, TEC, TNK1, TYK2, and YES.{27326} It inhibits these kinases at low micromolar concentrations and can be immobilized to capture and purify these enzymes.{27326}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • CZC-8004 is an aminopyrimidine that binds a range of tyrosine kinases, including ABL, BTK, FAK, FER, JAK1, SRC, SYK, TEC, TNK1, TYK2, and YES.{27326} It inhibits these kinases at low micromolar concentrations and can be immobilized to capture and purify these enzymes.{27326}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • CZC-8004 is an aminopyrimidine that binds a range of tyrosine kinases, including ABL, BTK, FAK, FER, JAK1, SRC, SYK, TEC, TNK1, TYK2, and YES.{27326} It inhibits these kinases at low micromolar concentrations and can be immobilized to capture and purify these enzymes.{27326}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • CZC-8004 is an aminopyrimidine that binds a range of tyrosine kinases, including ABL, BTK, FAK, FER, JAK1, SRC, SYK, TEC, TNK1, TYK2, and YES.{27326} It inhibits these kinases at low micromolar concentrations and can be immobilized to capture and purify these enzymes.{27326}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D 4476 is a cell-permeant inhibitor of casein kinase 1 (CK1; IC50 = 200 nM from S. pombe,{17330} 300 nM for CK1δ{17331}). It is a less effective inhibitor of PKD1 (IC50 = 9.1 μM) and p38α MAPK (IC50 = 5.8 μM), and only weakly affects the activities of a panel of kinases tested.{17331} D 4476 blocks CK1-mediated phosphorylation of FOXO1a,{17330} RhoB,{17333} and p53.{17334} As an inhibitor of ALK5, D 4476 prevents Smad3 activation and suppresses TGF-β1-induced gene expression without cytotoxicity in A498 cells.{16928}  

     

    Brand:
    Cayman
    SKU:-
  • D 4476 is a cell-permeant inhibitor of casein kinase 1 (CK1; IC50 = 200 nM from S. pombe,{17330} 300 nM for CK1δ{17331}). It is a less effective inhibitor of PKD1 (IC50 = 9.1 μM) and p38α MAPK (IC50 = 5.8 μM), and only weakly affects the activities of a panel of kinases tested.{17331} D 4476 blocks CK1-mediated phosphorylation of FOXO1a,{17330} RhoB,{17333} and p53.{17334} As an inhibitor of ALK5, D 4476 prevents Smad3 activation and suppresses TGF-β1-induced gene expression without cytotoxicity in A498 cells.{16928}  

     

    Brand:
    Cayman
    SKU:-
  • D 4476 is a cell-permeant inhibitor of casein kinase 1 (CK1; IC50 = 200 nM from S. pombe,{17330} 300 nM for CK1δ{17331}). It is a less effective inhibitor of PKD1 (IC50 = 9.1 μM) and p38α MAPK (IC50 = 5.8 μM), and only weakly affects the activities of a panel of kinases tested.{17331} D 4476 blocks CK1-mediated phosphorylation of FOXO1a,{17330} RhoB,{17333} and p53.{17334} As an inhibitor of ALK5, D 4476 prevents Smad3 activation and suppresses TGF-β1-induced gene expression without cytotoxicity in A498 cells.{16928}  

     

    Brand:
    Cayman
    SKU:-
  • D 4476 is a cell-permeant inhibitor of casein kinase 1 (CK1; IC50 = 200 nM from S. pombe,{17330} 300 nM for CK1δ{17331}). It is a less effective inhibitor of PKD1 (IC50 = 9.1 μM) and p38α MAPK (IC50 = 5.8 μM), and only weakly affects the activities of a panel of kinases tested.{17331} D 4476 blocks CK1-mediated phosphorylation of FOXO1a,{17330} RhoB,{17333} and p53.{17334} As an inhibitor of ALK5, D 4476 prevents Smad3 activation and suppresses TGF-β1-induced gene expression without cytotoxicity in A498 cells.{16928}  

     

    Brand:
    Cayman
    SKU:-
  • D-(+)-Glucose is a monosaccharide that occurs in nature and is used by organisms as an energy source. D-(+)-Glucose is the more common enantiomer of L-(–)-glucose (Item No. 20829).  

     

    Brand:
    Cayman
    SKU:23733 - 50 g

    Available on backorder

  • D-(+)-Glucose-13C6 is intended for use as an internal standard for the quantification of D-(+)-glucose (Item No. 23733) by GC- or LC-MS. D-(+)-Glucose is a monosaccharide that occurs in nature and is used by organisms as an energy source. D-(+)-Glucose is the more common enantiomer of L-(–)-glucose (Item No. 20829).  

     

    Brand:
    Cayman
    SKU:26707 - 1 g

    Available on backorder

  • D-(+)-Glucose-13C6 is intended for use as an internal standard for the quantification of D-(+)-glucose (Item No. 23733) by GC- or LC-MS. D-(+)-Glucose is a monosaccharide that occurs in nature and is used by organisms as an energy source. D-(+)-Glucose is the more common enantiomer of L-(–)-glucose (Item No. 20829).  

     

    Brand:
    Cayman
    SKU:26707 - 100 mg

    Available on backorder

  • D-(+)-Glucose-13C6 is intended for use as an internal standard for the quantification of D-(+)-glucose (Item No. 23733) by GC- or LC-MS. D-(+)-Glucose is a monosaccharide that occurs in nature and is used by organisms as an energy source. D-(+)-Glucose is the more common enantiomer of L-(–)-glucose (Item No. 20829).  

     

    Brand:
    Cayman
    SKU:26707 - 250 mg

    Available on backorder

  • D-(+)-Glucose-13C6 is intended for use as an internal standard for the quantification of D-(+)-glucose (Item No. 23733) by GC- or LC-MS. D-(+)-Glucose is a monosaccharide that occurs in nature and is used by organisms as an energy source. D-(+)-Glucose is the more common enantiomer of L-(–)-glucose (Item No. 20829).  

     

    Brand:
    Cayman
    SKU:26707 - 500 mg

    Available on backorder

  • D-(+)-Glyceraldehyde is an intermediate in carbohydrate metabolism. It is phosphorylated by triose kinase to produce D-glyceraldehyde 3-phosphate, an intermediate in glycolysis, gluconeogenesis, photosynthesis, and other metabolic pathways.{29575,29576,29577}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D-(+)-Glyceraldehyde is an intermediate in carbohydrate metabolism. It is phosphorylated by triose kinase to produce D-glyceraldehyde 3-phosphate, an intermediate in glycolysis, gluconeogenesis, photosynthesis, and other metabolic pathways.{29575,29576,29577}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D-(+)-Glyceraldehyde is an intermediate in carbohydrate metabolism. It is phosphorylated by triose kinase to produce D-glyceraldehyde 3-phosphate, an intermediate in glycolysis, gluconeogenesis, photosynthesis, and other metabolic pathways.{29575,29576,29577}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D-(+)-Raffinose is a trisaccharide composed of galactose, glucose, and fructose that occurs naturally in a variety of vegetables and grains. It is hydrolyzed to galactose and sucrose by α-galactosidase.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D-(+)-Raffinose is a trisaccharide composed of galactose, glucose, and fructose that occurs naturally in a variety of vegetables and grains. It is hydrolyzed to galactose and sucrose by α-galactosidase.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D-(+)-Raffinose is a trisaccharide composed of galactose, glucose, and fructose that occurs naturally in a variety of vegetables and grains. It is hydrolyzed to galactose and sucrose by α-galactosidase.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D-(+)-Raffinose is a trisaccharide composed of galactose, glucose, and fructose that occurs naturally in a variety of vegetables and grains. It is hydrolyzed to galactose and sucrose by α-galactosidase.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D-(−)-3-Phosphoglyceric acid is an intermediate in several biological pathways, most notably glycolysis/gluconeogenesis and the biosynthesis of serine, glycine, and threonine.{33169} It also has numerous roles as an intermediate in biosynthetic pathways in plants, eukaryotes, and prokaryotes.  

     

    Brand:
    Cayman
    SKU:20123 -

    Available on backorder

  • D-(−)-3-Phosphoglyceric acid is an intermediate in several biological pathways, most notably glycolysis/gluconeogenesis and the biosynthesis of serine, glycine, and threonine.{33169} It also has numerous roles as an intermediate in biosynthetic pathways in plants, eukaryotes, and prokaryotes.  

     

    Brand:
    Cayman
    SKU:20123 -

    Available on backorder

  • D-(−)-3-Phosphoglyceric acid is an intermediate in several biological pathways, most notably glycolysis/gluconeogenesis and the biosynthesis of serine, glycine, and threonine.{33169} It also has numerous roles as an intermediate in biosynthetic pathways in plants, eukaryotes, and prokaryotes.  

     

    Brand:
    Cayman
    SKU:20123 -

    Available on backorder

  • D-(−)-3-Phosphoglyceric acid is an intermediate in several biological pathways, most notably glycolysis/gluconeogenesis and the biosynthesis of serine, glycine, and threonine.{33169} It also has numerous roles as an intermediate in biosynthetic pathways in plants, eukaryotes, and prokaryotes.  

     

    Brand:
    Cayman
    SKU:20123 -

    Available on backorder

  • D-2-Aminoglutarimide is a synthetic intermediate.{52861} It has been used in the synthesis of hydantoins with anti-angiogenic and cancer cell differentiation-inducing activities.  

     

    Brand:
    Cayman
    SKU:31697 - 1 mg

    Available on backorder

  • D-2-Aminoglutarimide is a synthetic intermediate.{52861} It has been used in the synthesis of hydantoins with anti-angiogenic and cancer cell differentiation-inducing activities.  

     

    Brand:
    Cayman
    SKU:31697 - 10 mg

    Available on backorder

  • D-2-Aminoglutarimide is a synthetic intermediate.{52861} It has been used in the synthesis of hydantoins with anti-angiogenic and cancer cell differentiation-inducing activities.  

     

    Brand:
    Cayman
    SKU:31697 - 5 mg

    Available on backorder

  • D-64131 is an antimitotic agent that inhibits polymerization of microtubules with an IC50 value of 0.53 µM in a radioligand binding assay using purified tubules from bovine brain.{39215} It arrests the cell cycle at the G2/M transition (IC50 = 92 nM) and is preferentially cytotoxic to cycling cells. It has antiproliferative activity in cancer cell lines derived from various tissues and organs (IC50s = 24-144 nM) and in cell lines resistant to other tubulin inhibitors (IC50s = 20-77 nM). D-64131 (200 and 400 mg/kg) is also efficacious in reducing tumor growth in a mouse xenograft model of human amelanoic melanoma.  

     

    Brand:
    Cayman
    SKU:22944 - 10 mg

    Available on backorder

  • D-64131 is an antimitotic agent that inhibits polymerization of microtubules with an IC50 value of 0.53 µM in a radioligand binding assay using purified tubules from bovine brain.{39215} It arrests the cell cycle at the G2/M transition (IC50 = 92 nM) and is preferentially cytotoxic to cycling cells. It has antiproliferative activity in cancer cell lines derived from various tissues and organs (IC50s = 24-144 nM) and in cell lines resistant to other tubulin inhibitors (IC50s = 20-77 nM). D-64131 (200 and 400 mg/kg) is also efficacious in reducing tumor growth in a mouse xenograft model of human amelanoic melanoma.  

     

    Brand:
    Cayman
    SKU:22944 - 25 mg

    Available on backorder

  • D-64131 is an antimitotic agent that inhibits polymerization of microtubules with an IC50 value of 0.53 µM in a radioligand binding assay using purified tubules from bovine brain.{39215} It arrests the cell cycle at the G2/M transition (IC50 = 92 nM) and is preferentially cytotoxic to cycling cells. It has antiproliferative activity in cancer cell lines derived from various tissues and organs (IC50s = 24-144 nM) and in cell lines resistant to other tubulin inhibitors (IC50s = 20-77 nM). D-64131 (200 and 400 mg/kg) is also efficacious in reducing tumor growth in a mouse xenograft model of human amelanoic melanoma.  

     

    Brand:
    Cayman
    SKU:22944 - 5 mg

    Available on backorder

  • D-64131 is an antimitotic agent that inhibits polymerization of microtubules with an IC50 value of 0.53 µM in a radioligand binding assay using purified tubules from bovine brain.{39215} It arrests the cell cycle at the G2/M transition (IC50 = 92 nM) and is preferentially cytotoxic to cycling cells. It has antiproliferative activity in cancer cell lines derived from various tissues and organs (IC50s = 24-144 nM) and in cell lines resistant to other tubulin inhibitors (IC50s = 20-77 nM). D-64131 (200 and 400 mg/kg) is also efficacious in reducing tumor growth in a mouse xenograft model of human amelanoic melanoma.  

     

    Brand:
    Cayman
    SKU:22944 - 50 mg

    Available on backorder

  • D-Amino acid oxidase inhibitor is an inhibitor of D-amino acid oxidase (DAAO) with IC50 values of 145 and 114 nM in CHO cells expressing human and rat DAAO, respectively.{41492} It is selective for DAAO over a panel of 150 enzymes, receptors, and ion channels when used at a concentration of 30 μM. D-Amino acid oxidase inhibitor (10-200 mg/kg, i.p.) inhibits DAAO activity in rat kidney and cerebellum in a dose- and time-dependent manner. It increases levels of D-serine in rat plasma and cerebral spinal fluid (CSF) but has no effect on hyperlocomotion or dopamine efflux in the nucleus accumbens induced by amphetamine (Item No. ISO60188) in rats. DAAO inhibitor reduces formalin-induced paw flinching in rats (EC50 = 0.17 μg per animal) indicating an antinociceptive effect.{41493}  

     

    Brand:
    Cayman
    SKU:23894 - 1 g

    Available on backorder

  • D-Amino acid oxidase inhibitor is an inhibitor of D-amino acid oxidase (DAAO) with IC50 values of 145 and 114 nM in CHO cells expressing human and rat DAAO, respectively.{41492} It is selective for DAAO over a panel of 150 enzymes, receptors, and ion channels when used at a concentration of 30 μM. D-Amino acid oxidase inhibitor (10-200 mg/kg, i.p.) inhibits DAAO activity in rat kidney and cerebellum in a dose- and time-dependent manner. It increases levels of D-serine in rat plasma and cerebral spinal fluid (CSF) but has no effect on hyperlocomotion or dopamine efflux in the nucleus accumbens induced by amphetamine (Item No. ISO60188) in rats. DAAO inhibitor reduces formalin-induced paw flinching in rats (EC50 = 0.17 μg per animal) indicating an antinociceptive effect.{41493}  

     

    Brand:
    Cayman
    SKU:23894 - 250 mg

    Available on backorder

  • D-Amino acid oxidase inhibitor is an inhibitor of D-amino acid oxidase (DAAO) with IC50 values of 145 and 114 nM in CHO cells expressing human and rat DAAO, respectively.{41492} It is selective for DAAO over a panel of 150 enzymes, receptors, and ion channels when used at a concentration of 30 μM. D-Amino acid oxidase inhibitor (10-200 mg/kg, i.p.) inhibits DAAO activity in rat kidney and cerebellum in a dose- and time-dependent manner. It increases levels of D-serine in rat plasma and cerebral spinal fluid (CSF) but has no effect on hyperlocomotion or dopamine efflux in the nucleus accumbens induced by amphetamine (Item No. ISO60188) in rats. DAAO inhibitor reduces formalin-induced paw flinching in rats (EC50 = 0.17 μg per animal) indicating an antinociceptive effect.{41493}  

     

    Brand:
    Cayman
    SKU:23894 - 5 g

    Available on backorder

  • D-Amino acid oxidase inhibitor is an inhibitor of D-amino acid oxidase (DAAO) with IC50 values of 145 and 114 nM in CHO cells expressing human and rat DAAO, respectively.{41492} It is selective for DAAO over a panel of 150 enzymes, receptors, and ion channels when used at a concentration of 30 μM. D-Amino acid oxidase inhibitor (10-200 mg/kg, i.p.) inhibits DAAO activity in rat kidney and cerebellum in a dose- and time-dependent manner. It increases levels of D-serine in rat plasma and cerebral spinal fluid (CSF) but has no effect on hyperlocomotion or dopamine efflux in the nucleus accumbens induced by amphetamine (Item No. ISO60188) in rats. DAAO inhibitor reduces formalin-induced paw flinching in rats (EC50 = 0.17 μg per animal) indicating an antinociceptive effect.{41493}  

     

    Brand:
    Cayman
    SKU:23894 - 500 mg

    Available on backorder

  • D-Amphetamine (hydrochloride) (exempt preparation) (Item No. 15650) is an analytical reference standard categorized as an amphetamine.{21437} Amphetamine is a psychotropic compound that is abused recreationally.{36004} Amphetamine is regulated as a Schedule II compound in the United States. D-Amphetamine (hydrochloride) (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:-
  • D-AP5 is a selective N-methyl-D-aspartate (NMDA) receptor antagonist (Kd = 1.4 μM) that competitively inhibits the glutamate binding site of NMDA receptors.{22827} Whereas D-AP5 is the active (−)-stereoisomer, its (+)-isomer (L-AP5) demonstrates considerably less potent NMDA receptor antagonist activity.{22827} AP5 has been widely used to study the activity of NMDA receptors particularly in regard to researching synaptic plasticity, learning, and memory.{22826}  

     

    Brand:
    Cayman
    SKU:-
  • D-AP5 is a selective N-methyl-D-aspartate (NMDA) receptor antagonist (Kd = 1.4 μM) that competitively inhibits the glutamate binding site of NMDA receptors.{22827} Whereas D-AP5 is the active (−)-stereoisomer, its (+)-isomer (L-AP5) demonstrates considerably less potent NMDA receptor antagonist activity.{22827} AP5 has been widely used to study the activity of NMDA receptors particularly in regard to researching synaptic plasticity, learning, and memory.{22826}  

     

    Brand:
    Cayman
    SKU:-
  • D-AP5 is a selective N-methyl-D-aspartate (NMDA) receptor antagonist (Kd = 1.4 μM) that competitively inhibits the glutamate binding site of NMDA receptors.{22827} Whereas D-AP5 is the active (−)-stereoisomer, its (+)-isomer (L-AP5) demonstrates considerably less potent NMDA receptor antagonist activity.{22827} AP5 has been widely used to study the activity of NMDA receptors particularly in regard to researching synaptic plasticity, learning, and memory.{22826}  

     

    Brand:
    Cayman
    SKU:-
  • D-AP5 is a selective N-methyl-D-aspartate (NMDA) receptor antagonist (Kd = 1.4 μM) that competitively inhibits the glutamate binding site of NMDA receptors.{22827} Whereas D-AP5 is the active (−)-stereoisomer, its (+)-isomer (L-AP5) demonstrates considerably less potent NMDA receptor antagonist activity.{22827} AP5 has been widely used to study the activity of NMDA receptors particularly in regard to researching synaptic plasticity, learning, and memory.{22826}  

     

    Brand:
    Cayman
    SKU:-
  • L-Carnitine is an essential metabolite that has diverse roles in metabolism, most notably facilitating the transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation.{27352,27356} L-Carnitine is obtained from dietary sources or by the metabolism of lysine and methioinine. D-Carnitine is an analog of L-carnitine that, in the range of 0.25-1 mM, inhibits the uptake of L-carnitine by cells.{27353,27355}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • L-Carnitine is an essential metabolite that has diverse roles in metabolism, most notably facilitating the transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation.{27352,27356} L-Carnitine is obtained from dietary sources or by the metabolism of lysine and methioinine. D-Carnitine is an analog of L-carnitine that, in the range of 0.25-1 mM, inhibits the uptake of L-carnitine by cells.{27353,27355}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • L-Carnitine is an essential metabolite that has diverse roles in metabolism, most notably facilitating the transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation.{27352,27356} L-Carnitine is obtained from dietary sources or by the metabolism of lysine and methioinine. D-Carnitine is an analog of L-carnitine that, in the range of 0.25-1 mM, inhibits the uptake of L-carnitine by cells.{27353,27355}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • L-Carnitine is an essential metabolite that has diverse roles in metabolism, most notably facilitating the transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation.{27352,27356} L-Carnitine is obtained from dietary sources or by the metabolism of lysine and methioinine. D-Carnitine is an analog of L-carnitine that, in the range of 0.25-1 mM, inhibits the uptake of L-carnitine by cells.{27353,27355}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • D-Cellobiose is a disaccharide that consists of two β-glucose molecules linked by a β-1,4 glycosidic bond. It can be used as a substrate of β-glucosidase.{32269}  

     

    Brand:
    Cayman
    SKU:20364 -

    Available on backorder

  • D-Cellobiose is a disaccharide that consists of two β-glucose molecules linked by a β-1,4 glycosidic bond. It can be used as a substrate of β-glucosidase.{32269}  

     

    Brand:
    Cayman
    SKU:20364 -

    Available on backorder

  • D-Cellobiose is a disaccharide that consists of two β-glucose molecules linked by a β-1,4 glycosidic bond. It can be used as a substrate of β-glucosidase.{32269}  

     

    Brand:
    Cayman
    SKU:20364 -

    Available on backorder

  • D-Cycloserine is an NMDA receptor (NMDAR) partial agonist with antibiotic activity. It selectively binds to the glycine binding site (Ki = 2.33 μM) over the glutamate binding site (Ki = >100 μM).{39065} D-Cycloserine modulates memory in a T-maze footshock test in CD-1 mice with optimal memory retention at doses of 10-30 mg/kg.{39066} Administration of D-cycloserine (20-40 mg/kg) improves memory retention in ‘senescence-accelerated’ mice which exhibit impaired learning and memory. D-Cycloserine inhibits L-alanine racemase and D-alanine:D-alanine ligase, enzymes essential to peptidoglycan synthesis and bacterial cell wall formation.{39068} Formulations containing D-cycloserine have been used as second-line agents to treat drug resistant tuberculosis.{39069}  

     

    Brand:
    Cayman
    SKU:22194 -

    Out of stock

  • D-Cycloserine is an NMDA receptor (NMDAR) partial agonist with antibiotic activity. It selectively binds to the glycine binding site (Ki = 2.33 μM) over the glutamate binding site (Ki = >100 μM).{39065} D-Cycloserine modulates memory in a T-maze footshock test in CD-1 mice with optimal memory retention at doses of 10-30 mg/kg.{39066} Administration of D-cycloserine (20-40 mg/kg) improves memory retention in ‘senescence-accelerated’ mice which exhibit impaired learning and memory. D-Cycloserine inhibits L-alanine racemase and D-alanine:D-alanine ligase, enzymes essential to peptidoglycan synthesis and bacterial cell wall formation.{39068} Formulations containing D-cycloserine have been used as second-line agents to treat drug resistant tuberculosis.{39069}  

     

    Brand:
    Cayman
    SKU:22194 -

    Out of stock

  • D-Cycloserine is an NMDA receptor (NMDAR) partial agonist with antibiotic activity. It selectively binds to the glycine binding site (Ki = 2.33 μM) over the glutamate binding site (Ki = >100 μM).{39065} D-Cycloserine modulates memory in a T-maze footshock test in CD-1 mice with optimal memory retention at doses of 10-30 mg/kg.{39066} Administration of D-cycloserine (20-40 mg/kg) improves memory retention in ‘senescence-accelerated’ mice which exhibit impaired learning and memory. D-Cycloserine inhibits L-alanine racemase and D-alanine:D-alanine ligase, enzymes essential to peptidoglycan synthesis and bacterial cell wall formation.{39068} Formulations containing D-cycloserine have been used as second-line agents to treat drug resistant tuberculosis.{39069}  

     

    Brand:
    Cayman
    SKU:22194 -

    Out of stock

  • D-Desthiobiotin is a protein cross-linking agent and a precursor in the synthesis of biotin (Item No. 22582).{57032} It has been used in the preparation of agarose matrices for affinity-based isolation of streptavidin-fluorophore conjugates.  

     

    Brand:
    Cayman
    SKU:30418 - 100 mg

    Available on backorder

  • D-Desthiobiotin is a protein cross-linking agent and a precursor in the synthesis of biotin (Item No. 22582).{57032} It has been used in the preparation of agarose matrices for affinity-based isolation of streptavidin-fluorophore conjugates.  

     

    Brand:
    Cayman
    SKU:30418 - 250 mg

    Available on backorder

  • D-Desthiobiotin is a protein cross-linking agent and a precursor in the synthesis of biotin (Item No. 22582).{57032} It has been used in the preparation of agarose matrices for affinity-based isolation of streptavidin-fluorophore conjugates.  

     

    Brand:
    Cayman
    SKU:30418 - 500 mg

    Available on backorder

  • D-DOPA is an enantiomer of the dopamine precursor L-DOPA (Item No. 13248). It can be converted to L-DOPA via sequential oxidation and transamination, which are mediated by D-amino acid oxidase (DAAO) and DOPA transaminase, respectively, in rat kidney homogenates.{57222} It reduces the number of dopaminergic neurons in primary rat embryonic mesencephalic cultures in a concentration-dependent manner.{57223} Intraventricular administration of D-DOPA (200 µg/animal) increases striatal dopamine levels in rats.{57224} D-DOPA (20 mg/kg, i.p.) induces contralateral turns in a rat model of Parkinson’s disease induced by 6-OHDA (Item No. 25330).{57225}  

     

    Brand:
    Cayman
    SKU:-
  • D-DOPA is an enantiomer of the dopamine precursor L-DOPA (Item No. 13248). It can be converted to L-DOPA via sequential oxidation and transamination, which are mediated by D-amino acid oxidase (DAAO) and DOPA transaminase, respectively, in rat kidney homogenates.{57222} It reduces the number of dopaminergic neurons in primary rat embryonic mesencephalic cultures in a concentration-dependent manner.{57223} Intraventricular administration of D-DOPA (200 µg/animal) increases striatal dopamine levels in rats.{57224} D-DOPA (20 mg/kg, i.p.) induces contralateral turns in a rat model of Parkinson’s disease induced by 6-OHDA (Item No. 25330).{57225}  

     

    Brand:
    Cayman
    SKU:-
  • D-DOPA is an enantiomer of the dopamine precursor L-DOPA (Item No. 13248). It can be converted to L-DOPA via sequential oxidation and transamination, which are mediated by D-amino acid oxidase (DAAO) and DOPA transaminase, respectively, in rat kidney homogenates.{57222} It reduces the number of dopaminergic neurons in primary rat embryonic mesencephalic cultures in a concentration-dependent manner.{57223} Intraventricular administration of D-DOPA (200 µg/animal) increases striatal dopamine levels in rats.{57224} D-DOPA (20 mg/kg, i.p.) induces contralateral turns in a rat model of Parkinson’s disease induced by 6-OHDA (Item No. 25330).{57225}  

     

    Brand:
    Cayman
    SKU:-
  • D-DOPA is an enantiomer of the dopamine precursor L-DOPA (Item No. 13248). It can be converted to L-DOPA via sequential oxidation and transamination, which are mediated by D-amino acid oxidase (DAAO) and DOPA transaminase, respectively, in rat kidney homogenates.{57222} It reduces the number of dopaminergic neurons in primary rat embryonic mesencephalic cultures in a concentration-dependent manner.{57223} Intraventricular administration of D-DOPA (200 µg/animal) increases striatal dopamine levels in rats.{57224} D-DOPA (20 mg/kg, i.p.) induces contralateral turns in a rat model of Parkinson’s disease induced by 6-OHDA (Item No. 25330).{57225}  

     

    Brand:
    Cayman
    SKU:-
  • D-Eritadenine is an adenosine analog and a potent, reversible inhibitor of S-adenosylhomocysteine hydrolase (SAAH; IC50 = 7 nM).{46113} It inhibits growth of C. parvum parasites (MIC50 = 3 μM) without exhibiting cytotoxicity in HCT-8 cells (CC50 = >1 mM).{46114} Dietary administration of D-eritadenine (50 mg/kg) increases liver microsomal phosphatidylethanolamine concentration and decreases liver microsomal Δ6 desaturase activity and plasma cholesterol levels in rats.{46115}  

     

    Brand:
    Cayman
    SKU:21747 -

    Out of stock

  • D-Eritadenine is an adenosine analog and a potent, reversible inhibitor of S-adenosylhomocysteine hydrolase (SAAH; IC50 = 7 nM).{46113} It inhibits growth of C. parvum parasites (MIC50 = 3 μM) without exhibiting cytotoxicity in HCT-8 cells (CC50 = >1 mM).{46114} Dietary administration of D-eritadenine (50 mg/kg) increases liver microsomal phosphatidylethanolamine concentration and decreases liver microsomal Δ6 desaturase activity and plasma cholesterol levels in rats.{46115}  

     

    Brand:
    Cayman
    SKU:21747 -

    Out of stock

  • D-Eritadenine is an adenosine analog and a potent, reversible inhibitor of S-adenosylhomocysteine hydrolase (SAAH; IC50 = 7 nM).{46113} It inhibits growth of C. parvum parasites (MIC50 = 3 μM) without exhibiting cytotoxicity in HCT-8 cells (CC50 = >1 mM).{46114} Dietary administration of D-eritadenine (50 mg/kg) increases liver microsomal phosphatidylethanolamine concentration and decreases liver microsomal Δ6 desaturase activity and plasma cholesterol levels in rats.{46115}  

     

    Brand:
    Cayman
    SKU:21747 -

    Out of stock

  • D-erythro Lysosphingomyelin is a bioactive sphingolipid.{37413} It is an agonist of sphingosine-1-phosphate receptor 1 (S1P1), S1P2, and S1P3 (EC50s = 167.7, 368.1, and 482.6 nM, respectively, for the human receptors). D-erythro Lysosphingomyelin is also an agonist of the orphan receptor ovarian cancer G protein-coupled receptor 1 (ORG1) that induces calcium accumulation in cells overexpressing OGR1 (EC50 = ~35 nM).{59108} Levels of D-erythro lysosphingomyelin are increased in skin isolated from patients with atopic dermatitis, as well as postmortem brain from patients with Niemann-Pick disease type A, but not type B.{18804,59109}  

     

    Brand:
    Cayman
    SKU:10007947 - 1 mg

    Available on backorder

  • D-erythro Lysosphingomyelin is a bioactive sphingolipid.{37413} It is an agonist of sphingosine-1-phosphate receptor 1 (S1P1), S1P2, and S1P3 (EC50s = 167.7, 368.1, and 482.6 nM, respectively, for the human receptors). D-erythro Lysosphingomyelin is also an agonist of the orphan receptor ovarian cancer G protein-coupled receptor 1 (ORG1) that induces calcium accumulation in cells overexpressing OGR1 (EC50 = ~35 nM).{59108} Levels of D-erythro lysosphingomyelin are increased in skin isolated from patients with atopic dermatitis, as well as postmortem brain from patients with Niemann-Pick disease type A, but not type B.{18804,59109}  

     

    Brand:
    Cayman
    SKU:10007947 - 10 mg

    Available on backorder

  • D-erythro Lysosphingomyelin is a bioactive sphingolipid.{37413} It is an agonist of sphingosine-1-phosphate receptor 1 (S1P1), S1P2, and S1P3 (EC50s = 167.7, 368.1, and 482.6 nM, respectively, for the human receptors). D-erythro Lysosphingomyelin is also an agonist of the orphan receptor ovarian cancer G protein-coupled receptor 1 (ORG1) that induces calcium accumulation in cells overexpressing OGR1 (EC50 = ~35 nM).{59108} Levels of D-erythro lysosphingomyelin are increased in skin isolated from patients with atopic dermatitis, as well as postmortem brain from patients with Niemann-Pick disease type A, but not type B.{18804,59109}  

     

    Brand:
    Cayman
    SKU:10007947 - 25 mg

    Available on backorder

  • D-erythro Lysosphingomyelin is a bioactive sphingolipid.{37413} It is an agonist of sphingosine-1-phosphate receptor 1 (S1P1), S1P2, and S1P3 (EC50s = 167.7, 368.1, and 482.6 nM, respectively, for the human receptors). D-erythro Lysosphingomyelin is also an agonist of the orphan receptor ovarian cancer G protein-coupled receptor 1 (ORG1) that induces calcium accumulation in cells overexpressing OGR1 (EC50 = ~35 nM).{59108} Levels of D-erythro lysosphingomyelin are increased in skin isolated from patients with atopic dermatitis, as well as postmortem brain from patients with Niemann-Pick disease type A, but not type B.{18804,59109}  

     

    Brand:
    Cayman
    SKU:10007947 - 5 mg

    Available on backorder

  • D-erythro-MAPP is a derivative of ceramide and an inhibitor of alkaline ceramidase (Ki = 2-13 µM; IC50 = 1-5 µM).{3672} It is selective for alkaline ceramidase over acid ceramidase (IC50 = >500 µM) as well as the serine/threonine protein phosphatase CAPP at concentrations up to 10 µM. D-erythro-MAPP increases intracellular ceramide levels, induces cell cycle arrest at the G0/G1 phase, and inhibits growth of HL-60 promyelocytic leukemia cells in a time- and concentration-dependent manner.  

     

    Brand:
    Cayman
    SKU:10165 - 1 mg

    Available on backorder

  • D-erythro-MAPP is a derivative of ceramide and an inhibitor of alkaline ceramidase (Ki = 2-13 µM; IC50 = 1-5 µM).{3672} It is selective for alkaline ceramidase over acid ceramidase (IC50 = >500 µM) as well as the serine/threonine protein phosphatase CAPP at concentrations up to 10 µM. D-erythro-MAPP increases intracellular ceramide levels, induces cell cycle arrest at the G0/G1 phase, and inhibits growth of HL-60 promyelocytic leukemia cells in a time- and concentration-dependent manner.  

     

    Brand:
    Cayman
    SKU:10165 - 10 mg

    Available on backorder

  • D-erythro-MAPP is a derivative of ceramide and an inhibitor of alkaline ceramidase (Ki = 2-13 µM; IC50 = 1-5 µM).{3672} It is selective for alkaline ceramidase over acid ceramidase (IC50 = >500 µM) as well as the serine/threonine protein phosphatase CAPP at concentrations up to 10 µM. D-erythro-MAPP increases intracellular ceramide levels, induces cell cycle arrest at the G0/G1 phase, and inhibits growth of HL-60 promyelocytic leukemia cells in a time- and concentration-dependent manner.  

     

    Brand:
    Cayman
    SKU:10165 - 5 mg

    Available on backorder

  • D-erythro-MAPP is a derivative of ceramide and an inhibitor of alkaline ceramidase (Ki = 2-13 µM; IC50 = 1-5 µM).{3672} It is selective for alkaline ceramidase over acid ceramidase (IC50 = >500 µM) as well as the serine/threonine protein phosphatase CAPP at concentrations up to 10 µM. D-erythro-MAPP increases intracellular ceramide levels, induces cell cycle arrest at the G0/G1 phase, and inhibits growth of HL-60 promyelocytic leukemia cells in a time- and concentration-dependent manner.  

     

    Brand:
    Cayman
    SKU:10165 - 500 µg

    Available on backorder

  • Lysosphingomyelin is an endogenous bioactive sphingolipid and a constituent of lipoproteins.{18803,18804} It is produced by the removal of the acyl group from sphingomyelin by a deacylase and acts as a precursor in the biosynthesis of sphingosine-1-phosphate (S1P; Item No. 62570). D-erythro Lysosphingomyelin is an agonist of the S1P receptors S1P1, S1P2, and S1P3 (EC50s = 167.7, 368.1, and 482.6 nM, respectively, for the human receptors).{37413} It is also an agonist of the orphan receptor ovarian cancer G protein-coupled receptor 1 (ORG1) that induces calcium accumulation in cells overexpressing OGR1 (EC50 = ~35 nM).{59108} Levels of D-erythro lysosphingomyelin are increased in skin isolated from patients with atopic dermatitis, as well as postmortem brain from patients with Niemann-Pick disease type A, but not type B.{18804,59109} L-threo lysosphingomyelin is also an S1P1-3 agonist (EC50s = 19.3, 131.8, and 313.3 nM, respectively).{37413} This product is a mixture of D-erythro and L-threo lysosphingomyelin. [Matreya, LLC. Catalog No. 1321]  

     

    Brand:
    Cayman
    SKU:31557 - 10 mg

    Available on backorder

  • Lysosphingomyelin is an endogenous bioactive sphingolipid and a constituent of lipoproteins.{18803,18804} It is produced by the removal of the acyl group from sphingomyelin by a deacylase and acts as a precursor in the biosynthesis of sphingosine-1-phosphate (S1P; Item No. 62570). D-erythro Lysosphingomyelin is an agonist of the S1P receptors S1P1, S1P2, and S1P3 (EC50s = 167.7, 368.1, and 482.6 nM, respectively, for the human receptors).{37413} It is also an agonist of the orphan receptor ovarian cancer G protein-coupled receptor 1 (ORG1) that induces calcium accumulation in cells overexpressing OGR1 (EC50 = ~35 nM).{59108} Levels of D-erythro lysosphingomyelin are increased in skin isolated from patients with atopic dermatitis, as well as postmortem brain from patients with Niemann-Pick disease type A, but not type B.{18804,59109} L-threo lysosphingomyelin is also an S1P1-3 agonist (EC50s = 19.3, 131.8, and 313.3 nM, respectively).{37413} This product is a mixture of D-erythro and L-threo lysosphingomyelin. [Matreya, LLC. Catalog No. 1321]  

     

    Brand:
    Cayman
    SKU:31557 - 5 mg

    Available on backorder

  • Lysosphingomyelin is an endogenous bioactive sphingolipid and a constituent of lipoproteins.{18803,18804} It is produced by the removal of the acyl group from sphingomyelin by a deacylase and acts as a precursor in the biosynthesis of sphingosine-1-phosphate (S1P; Item No. 62570). D-erythro Lysosphingomyelin is an agonist of the S1P receptors S1P1, S1P2, and S1P3 (EC50s = 167.7, 368.1, and 482.6 nM, respectively, for the human receptors).{37413} It is also an agonist of the orphan receptor ovarian cancer G protein-coupled receptor 1 (ORG1) that induces calcium accumulation in cells overexpressing OGR1 (EC50 = ~35 nM).{59108} Levels of D-erythro lysosphingomyelin are increased in skin isolated from patients with atopic dermatitis, as well as postmortem brain from patients with Niemann-Pick disease type A, but not type B.{18804,59109} L-threo lysosphingomyelin is also an S1P1-3 agonist (EC50s = 19.3, 131.8, and 313.3 nM, respectively).{37413} This product is a mixture of D-erythro and L-threo lysosphingomyelin. [Matreya, LLC. Catalog No. 1321]  

     

    Brand:
    Cayman
    SKU:31557 - 50 mg

    Available on backorder

  • D-Fructose-1,6-bisphosphate is an intermediate in carbohydrate metabolism, including glycolysis and gluconeogenesis. During glycolysis, it is generated by the phosphorylation of fructose-6-phosphate by phosphofructokinase. The reverse reaction, mediated by fructose-1,6-bisphosphatase-1, is one of the rate-limiting steps in gluconeogenesis.{20168,20167} The same reaction occurs within chloroplasts in plants as part of the reductive pentose phosphate cycle.{29577} Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a major target for cancer chemotherapy.{27006}  

     

    Brand:
    Cayman
    SKU:20516 -

    Available on backorder

  • D-Fructose-1,6-bisphosphate is an intermediate in carbohydrate metabolism, including glycolysis and gluconeogenesis. During glycolysis, it is generated by the phosphorylation of fructose-6-phosphate by phosphofructokinase. The reverse reaction, mediated by fructose-1,6-bisphosphatase-1, is one of the rate-limiting steps in gluconeogenesis.{20168,20167} The same reaction occurs within chloroplasts in plants as part of the reductive pentose phosphate cycle.{29577} Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a major target for cancer chemotherapy.{27006}  

     

    Brand:
    Cayman
    SKU:20516 -

    Available on backorder

  • D-Fructose-1,6-bisphosphate is an intermediate in carbohydrate metabolism, including glycolysis and gluconeogenesis. During glycolysis, it is generated by the phosphorylation of fructose-6-phosphate by phosphofructokinase. The reverse reaction, mediated by fructose-1,6-bisphosphatase-1, is one of the rate-limiting steps in gluconeogenesis.{20168,20167} The same reaction occurs within chloroplasts in plants as part of the reductive pentose phosphate cycle.{29577} Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a major target for cancer chemotherapy.{27006}  

     

    Brand:
    Cayman
    SKU:20516 -

    Available on backorder

  • D-Fructose-1,6-bisphosphate is an intermediate in carbohydrate metabolism, including glycolysis and gluconeogenesis. During glycolysis, it is generated by the phosphorylation of fructose-6-phosphate by phosphofructokinase. The reverse reaction, mediated by fructose-1,6-bisphosphatase-1, is one of the rate-limiting steps in gluconeogenesis.{20168,20167} The same reaction occurs within chloroplasts in plants as part of the reductive pentose phosphate cycle.{29577} Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a major target for cancer chemotherapy.{27006}  

     

    Brand:
    Cayman
    SKU:20516 -

    Available on backorder

  • D-Fructose-13C6 is intended for use as an internal standard for the quantification of D-fructose by GC- or LC-MS. D-Fructose is a ubiquitous monosaccharide and is derived, in addition to glucose, from the breakdown of sucrose by sucrase in the intestine.{45964} It is a precursor in the biosynthesis of D-fructose-1,6-bisphosphate (Item No. 20516), which is an intermediate in the production of D-glucose via gluconeogenesis. Deficiencies in the enzymes that metabolize D-fructose are inborn errors of metabolism that range from benign, for fructokinase deficiency, to severe, for hereditary fructose intolerance, if D-fructose, sucrose, and sorbitol are not eliminated from the diet.{45965} Increased consumption of D-fructose is associated with obesity, dyslipidemia, and impaired insulin sensitivity.{45966}  

     

    Brand:
    Cayman
    SKU:30071 - 100 mg

    Available on backorder

  • D-Fructose-13C6 is intended for use as an internal standard for the quantification of D-fructose by GC- or LC-MS. D-Fructose is a ubiquitous monosaccharide and is derived, in addition to glucose, from the breakdown of sucrose by sucrase in the intestine.{45964} It is a precursor in the biosynthesis of D-fructose-1,6-bisphosphate (Item No. 20516), which is an intermediate in the production of D-glucose via gluconeogenesis. Deficiencies in the enzymes that metabolize D-fructose are inborn errors of metabolism that range from benign, for fructokinase deficiency, to severe, for hereditary fructose intolerance, if D-fructose, sucrose, and sorbitol are not eliminated from the diet.{45965} Increased consumption of D-fructose is associated with obesity, dyslipidemia, and impaired insulin sensitivity.{45966}  

     

    Brand:
    Cayman
    SKU:30071 - 250 mg

    Available on backorder

  • D-Fructose-13C6 is intended for use as an internal standard for the quantification of D-fructose by GC- or LC-MS. D-Fructose is a ubiquitous monosaccharide and is derived, in addition to glucose, from the breakdown of sucrose by sucrase in the intestine.{45964} It is a precursor in the biosynthesis of D-fructose-1,6-bisphosphate (Item No. 20516), which is an intermediate in the production of D-glucose via gluconeogenesis. Deficiencies in the enzymes that metabolize D-fructose are inborn errors of metabolism that range from benign, for fructokinase deficiency, to severe, for hereditary fructose intolerance, if D-fructose, sucrose, and sorbitol are not eliminated from the diet.{45965} Increased consumption of D-fructose is associated with obesity, dyslipidemia, and impaired insulin sensitivity.{45966}  

     

    Brand:
    Cayman
    SKU:30071 - 500 mg

    Available on backorder

  • D-Fructose-6-phosphate is a sugar intermediate of the glycolytic pathway formed by the isomerization of glucose-6-phosphate. It is in turn further phosphorylated to fructose-1,6-bisphosphate, which is one of the rate-limiting steps in glycolysis. Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a new target for cancer chemotherapy.{27006} D-Fructose-6-phophate can be used to help identify, differentiate, and characterize the enzymes in this process.  

     

    Brand:
    Cayman
    SKU:19588 -

    Available on backorder

  • D-Fructose-6-phosphate is a sugar intermediate of the glycolytic pathway formed by the isomerization of glucose-6-phosphate. It is in turn further phosphorylated to fructose-1,6-bisphosphate, which is one of the rate-limiting steps in glycolysis. Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a new target for cancer chemotherapy.{27006} D-Fructose-6-phophate can be used to help identify, differentiate, and characterize the enzymes in this process.  

     

    Brand:
    Cayman
    SKU:19588 -

    Available on backorder

  • D-Fructose-6-phosphate is a sugar intermediate of the glycolytic pathway formed by the isomerization of glucose-6-phosphate. It is in turn further phosphorylated to fructose-1,6-bisphosphate, which is one of the rate-limiting steps in glycolysis. Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a new target for cancer chemotherapy.{27006} D-Fructose-6-phophate can be used to help identify, differentiate, and characterize the enzymes in this process.  

     

    Brand:
    Cayman
    SKU:19588 -

    Available on backorder

  • D-Galactosamine is an amino sugar derivative of D-galactose (Item No. 20890). D-Galactosamine is hepatotoxic and is used, alone or in combination with LPS, as a model of liver failure in rodents.{41036,41037,41038}  

     

    Brand:
    Cayman
    SKU:22981 - 1 g

    Available on backorder

  • D-Galactosamine is an amino sugar derivative of D-galactose (Item No. 20890). D-Galactosamine is hepatotoxic and is used, alone or in combination with LPS, as a model of liver failure in rodents.{41036,41037,41038}  

     

    Brand:
    Cayman
    SKU:22981 - 10 g

    Available on backorder

  • D-Galactosamine is an amino sugar derivative of D-galactose (Item No. 20890). D-Galactosamine is hepatotoxic and is used, alone or in combination with LPS, as a model of liver failure in rodents.{41036,41037,41038}  

     

    Brand:
    Cayman
    SKU:22981 - 25 g

    Available on backorder

  • D-Galactosamine is an amino sugar derivative of D-galactose (Item No. 20890). D-Galactosamine is hepatotoxic and is used, alone or in combination with LPS, as a model of liver failure in rodents.{41036,41037,41038}  

     

    Brand:
    Cayman
    SKU:22981 - 5 g

    Available on backorder

  • D-Galactose is a natural aldohexose and C-4 epimer of glucose. D-galactose is converted enzymatically into D-glucose for metabolism or polysaccharides for storage. Chronic, systemic exposure to D-galactose accelerates senescence in invertebrates and mammals and has been used as a model for aging.{33019} In bacteria, D-galactose is imported by a methyl-galactoside transport system to drive chemotaxis.{33018}  

     

    Brand:
    Cayman
    SKU:20890 -

    Out of stock

  • D-Galactose is a natural aldohexose and C-4 epimer of glucose. D-galactose is converted enzymatically into D-glucose for metabolism or polysaccharides for storage. Chronic, systemic exposure to D-galactose accelerates senescence in invertebrates and mammals and has been used as a model for aging.{33019} In bacteria, D-galactose is imported by a methyl-galactoside transport system to drive chemotaxis.{33018}  

     

    Brand:
    Cayman
    SKU:20890 -

    Out of stock

  • D-Galactose is a natural aldohexose and C-4 epimer of glucose. D-galactose is converted enzymatically into D-glucose for metabolism or polysaccharides for storage. Chronic, systemic exposure to D-galactose accelerates senescence in invertebrates and mammals and has been used as a model for aging.{33019} In bacteria, D-galactose is imported by a methyl-galactoside transport system to drive chemotaxis.{33018}  

     

    Brand:
    Cayman
    SKU:20890 -

    Out of stock

  • D-Galactose is a natural aldohexose and C-4 epimer of glucose. D-galactose is converted enzymatically into D-glucose for metabolism or polysaccharides for storage. Chronic, systemic exposure to D-galactose accelerates senescence in invertebrates and mammals and has been used as a model for aging.{33019} In bacteria, D-galactose is imported by a methyl-galactoside transport system to drive chemotaxis.{33018}  

     

    Brand:
    Cayman
    SKU:20890 -

    Out of stock

  • D-Glucosamine is an amino monosaccharide and a precursor in the biosynthesis of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc; Item No. 20353) via the hexosamine pathway.{47389,47390} It increases mineralization of MC3T3-E1 mouse osteoblastic cells when used at concentrations of 0.1 and 1 mM.{47391} D-Glucosamine (20 mg/kg per day) inhibits bone erosion and loss of glycosaminoglycans and proteoglycans in joints in a mouse model of collagenase-induced osteoarthritis.{47390}  

     

    Brand:
    Cayman
    SKU:27055 - 100 g

    Available on backorder

  • D-Glucosamine is an amino monosaccharide and a precursor in the biosynthesis of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc; Item No. 20353) via the hexosamine pathway.{47389,47390} It increases mineralization of MC3T3-E1 mouse osteoblastic cells when used at concentrations of 0.1 and 1 mM.{47391} D-Glucosamine (20 mg/kg per day) inhibits bone erosion and loss of glycosaminoglycans and proteoglycans in joints in a mouse model of collagenase-induced osteoarthritis.{47390}  

     

    Brand:
    Cayman
    SKU:27055 - 250 g

    Available on backorder

  • D-Glucosamine is an amino monosaccharide and a precursor in the biosynthesis of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc; Item No. 20353) via the hexosamine pathway.{47389,47390} It increases mineralization of MC3T3-E1 mouse osteoblastic cells when used at concentrations of 0.1 and 1 mM.{47391} D-Glucosamine (20 mg/kg per day) inhibits bone erosion and loss of glycosaminoglycans and proteoglycans in joints in a mouse model of collagenase-induced osteoarthritis.{47390}  

     

    Brand:
    Cayman
    SKU:27055 - 500 g

    Available on backorder

  • D-Glucosamine-6-sulfate is a naturally occurring glycosaminoglycan.{39435} It activates the glmS ribozyme from B. subtilis, a Gram-positive bacterium, when used at a concentration of 200 µM.{40617} It has been used to form polyvalent dendrimer conjugates that inhibit angiogenesis and endothelial cell proliferation induced by FGF-2 in vitro and prevent scar tissue formation in a rabbit model of glaucoma surgery.{40618}  

     

    Brand:
    Cayman
    SKU:23097 - 10 mg

    Available on backorder

  • D-Glucosamine-6-sulfate is a naturally occurring glycosaminoglycan.{39435} It activates the glmS ribozyme from B. subtilis, a Gram-positive bacterium, when used at a concentration of 200 µM.{40617} It has been used to form polyvalent dendrimer conjugates that inhibit angiogenesis and endothelial cell proliferation induced by FGF-2 in vitro and prevent scar tissue formation in a rabbit model of glaucoma surgery.{40618}  

     

    Brand:
    Cayman
    SKU:23097 - 100 mg

    Available on backorder

  • D-Glucosamine-6-sulfate is a naturally occurring glycosaminoglycan.{39435} It activates the glmS ribozyme from B. subtilis, a Gram-positive bacterium, when used at a concentration of 200 µM.{40617} It has been used to form polyvalent dendrimer conjugates that inhibit angiogenesis and endothelial cell proliferation induced by FGF-2 in vitro and prevent scar tissue formation in a rabbit model of glaucoma surgery.{40618}  

     

    Brand:
    Cayman
    SKU:23097 - 250 mg

    Available on backorder

  • D-Glucosamine-6-sulfate is a naturally occurring glycosaminoglycan.{39435} It activates the glmS ribozyme from B. subtilis, a Gram-positive bacterium, when used at a concentration of 200 µM.{40617} It has been used to form polyvalent dendrimer conjugates that inhibit angiogenesis and endothelial cell proliferation induced by FGF-2 in vitro and prevent scar tissue formation in a rabbit model of glaucoma surgery.{40618}  

     

    Brand:
    Cayman
    SKU:23097 - 50 mg

    Available on backorder

  • D-Glucose-6-phosphate is formed in cells when glucose is phosphorylated by hexokinase (or glucokinase) or by the conversion of glucose-1-phosphate by phosphoglucomutase, which is the first step of glycogen synthesis.{20949} It is stored as glycogen when blood glucose levels are high. Disruption of D-glucose-6-phosphate activity leads to glycogen storage disease type I or von Gierke’s disease, a group of inherited metabolic diseases characterized by severe hypoglycemia, growth retardation, and hepatomegaly, due to accumulation of glycogen and fat in the liver.{19698,19697} D-Glucose-6-phosphate is also the starting molecule of both glycolysis and the pentose phosphate pathways.{19695} Because cancer cells adopt glycolysis as a major source of metabolic energy production, and the pentose phosphate pathway plays a role in helping glycolytic cancer cells to meet their anabolic demands, this compound can be used to study the progression of this process.{26683}  

     

    Brand:
    Cayman
    SKU:20376 -

    Available on backorder

  • D-Glucose-6-phosphate is formed in cells when glucose is phosphorylated by hexokinase (or glucokinase) or by the conversion of glucose-1-phosphate by phosphoglucomutase, which is the first step of glycogen synthesis.{20949} It is stored as glycogen when blood glucose levels are high. Disruption of D-glucose-6-phosphate activity leads to glycogen storage disease type I or von Gierke’s disease, a group of inherited metabolic diseases characterized by severe hypoglycemia, growth retardation, and hepatomegaly, due to accumulation of glycogen and fat in the liver.{19698,19697} D-Glucose-6-phosphate is also the starting molecule of both glycolysis and the pentose phosphate pathways.{19695} Because cancer cells adopt glycolysis as a major source of metabolic energy production, and the pentose phosphate pathway plays a role in helping glycolytic cancer cells to meet their anabolic demands, this compound can be used to study the progression of this process.{26683}  

     

    Brand:
    Cayman
    SKU:20376 -

    Available on backorder

  • D-Glucose-6-phosphate is formed in cells when glucose is phosphorylated by hexokinase (or glucokinase) or by the conversion of glucose-1-phosphate by phosphoglucomutase, which is the first step of glycogen synthesis.{20949} It is stored as glycogen when blood glucose levels are high. Disruption of D-glucose-6-phosphate activity leads to glycogen storage disease type I or von Gierke’s disease, a group of inherited metabolic diseases characterized by severe hypoglycemia, growth retardation, and hepatomegaly, due to accumulation of glycogen and fat in the liver.{19698,19697} D-Glucose-6-phosphate is also the starting molecule of both glycolysis and the pentose phosphate pathways.{19695} Because cancer cells adopt glycolysis as a major source of metabolic energy production, and the pentose phosphate pathway plays a role in helping glycolytic cancer cells to meet their anabolic demands, this compound can be used to study the progression of this process.{26683}  

     

    Brand:
    Cayman
    SKU:20376 -

    Available on backorder

  • D-glutamic acid is an amino acid and a component of bacterial peptidoglycan.{52869} It is linked to UDP-N-acetylmuramoyl-L-alanine (UDP-MurNAc-L-Ala) by the muramyl ligase MurD to form UDP-MurNAc-L-Ala-D-glutamic acid, a building block in the biosynthesis of bacterial peptidoglycan. D-glutamic acid is also a component of poly-γ-glutamic acid, a polymer produced by Bacillus.{52870}  

     

    Brand:
    Cayman
    SKU:31503 - 10 g

    Available on backorder

  • D-glutamic acid is an amino acid and a component of bacterial peptidoglycan.{52869} It is linked to UDP-N-acetylmuramoyl-L-alanine (UDP-MurNAc-L-Ala) by the muramyl ligase MurD to form UDP-MurNAc-L-Ala-D-glutamic acid, a building block in the biosynthesis of bacterial peptidoglycan. D-glutamic acid is also a component of poly-γ-glutamic acid, a polymer produced by Bacillus.{52870}  

     

    Brand:
    Cayman
    SKU:31503 - 100 g

    Available on backorder

  • D-glutamic acid is an amino acid and a component of bacterial peptidoglycan.{52869} It is linked to UDP-N-acetylmuramoyl-L-alanine (UDP-MurNAc-L-Ala) by the muramyl ligase MurD to form UDP-MurNAc-L-Ala-D-glutamic acid, a building block in the biosynthesis of bacterial peptidoglycan. D-glutamic acid is also a component of poly-γ-glutamic acid, a polymer produced by Bacillus.{52870}  

     

    Brand:
    Cayman
    SKU:31503 - 25 g

    Available on backorder

  • D-glutamic acid is an amino acid and a component of bacterial peptidoglycan.{52869} It is linked to UDP-N-acetylmuramoyl-L-alanine (UDP-MurNAc-L-Ala) by the muramyl ligase MurD to form UDP-MurNAc-L-Ala-D-glutamic acid, a building block in the biosynthesis of bacterial peptidoglycan. D-glutamic acid is also a component of poly-γ-glutamic acid, a polymer produced by Bacillus.{52870}  

     

    Brand:
    Cayman
    SKU:31503 - 50 g

    Available on backorder

  • D-Glutamine is an enantiomer of the non-essential amino acid L-glutamine (Item No. 23716). D-Glutamine levels are reduced in the serum of rats in a model of acute pancreatitis.{43939} Serum levels of D-glutamine are also reduced in patients with hepatocellular carcinoma.{43940}  

     

    Brand:
    Cayman
    SKU:27032 - 1 g

    Available on backorder

  • D-Glutamine is an enantiomer of the non-essential amino acid L-glutamine (Item No. 23716). D-Glutamine levels are reduced in the serum of rats in a model of acute pancreatitis.{43939} Serum levels of D-glutamine are also reduced in patients with hepatocellular carcinoma.{43940}  

     

    Brand:
    Cayman
    SKU:27032 - 10 g

    Available on backorder

  • D-Glutamine is an enantiomer of the non-essential amino acid L-glutamine (Item No. 23716). D-Glutamine levels are reduced in the serum of rats in a model of acute pancreatitis.{43939} Serum levels of D-glutamine are also reduced in patients with hepatocellular carcinoma.{43940}  

     

    Brand:
    Cayman
    SKU:27032 - 25 g

    Available on backorder

  • D-Glutamine is an enantiomer of the non-essential amino acid L-glutamine (Item No. 23716). D-Glutamine levels are reduced in the serum of rats in a model of acute pancreatitis.{43939} Serum levels of D-glutamine are also reduced in patients with hepatocellular carcinoma.{43940}  

     

    Brand:
    Cayman
    SKU:27032 - 5 g

    Available on backorder

  • D-Kynurenine is an antagonist of hydroxycarboxylic acid receptor 3 HCA3/GPR109B (EC50 = 2.61 µM in a luciferase reporter assay) and a metabolite of D-tryptophan.{46426} It increases levels of intracellular calcium and decreases forskolin-stimulated production of cAMP in CHO cells expressing human HCA3/GPR109B when used at concentrations of 10 and 100, or 1,000 µM, respectively. D-Kynurenine (10 µM) increases expression of vimentin and decreases expression of E-cadherin in 95D lung cancer cells.{46427} It has been used as a substrate in fluorometric assays for D-amino acid oxidase activity.{46428,46429}  

     

    Brand:
    Cayman
    SKU:28254 - 100 mg

    Available on backorder

  • D-Kynurenine is an antagonist of hydroxycarboxylic acid receptor 3 HCA3/GPR109B (EC50 = 2.61 µM in a luciferase reporter assay) and a metabolite of D-tryptophan.{46426} It increases levels of intracellular calcium and decreases forskolin-stimulated production of cAMP in CHO cells expressing human HCA3/GPR109B when used at concentrations of 10 and 100, or 1,000 µM, respectively. D-Kynurenine (10 µM) increases expression of vimentin and decreases expression of E-cadherin in 95D lung cancer cells.{46427} It has been used as a substrate in fluorometric assays for D-amino acid oxidase activity.{46428,46429}  

     

    Brand:
    Cayman
    SKU:28254 - 250 mg

    Available on backorder

  • D-Kynurenine is an antagonist of hydroxycarboxylic acid receptor 3 HCA3/GPR109B (EC50 = 2.61 µM in a luciferase reporter assay) and a metabolite of D-tryptophan.{46426} It increases levels of intracellular calcium and decreases forskolin-stimulated production of cAMP in CHO cells expressing human HCA3/GPR109B when used at concentrations of 10 and 100, or 1,000 µM, respectively. D-Kynurenine (10 µM) increases expression of vimentin and decreases expression of E-cadherin in 95D lung cancer cells.{46427} It has been used as a substrate in fluorometric assays for D-amino acid oxidase activity.{46428,46429}  

     

    Brand:
    Cayman
    SKU:28254 - 50 mg

    Available on backorder